On the right, the GBM cells with originally low BICD1 expression, after exposure to a DNA-damaging agent, may experience up-regulation of BICD1 and thus, acquire adaptive resistance to DNA damage via EMT. This evidence concerns the gene BICD1 and glioblastoma.